Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 03, 2017 08:30 ET | Source: Centre for the Commercialization of Antibodies and Biologics

CCAB Signs Collaboration and License Agreement With Pionyr Immunotherapeutics Inc. to Discover Antibody Drug Development Candidates

TORONTO, April 03, 2017 (GLOBE NEWSWIRE) -- The Centre for the Commercialization of Antibodies and Biologics (CCAB), through the University of Toronto, has granted a non-exclusive license to Pionyr...